Skip to product information
1 of 1

Alexa Fluor® 647 Rat Anti-Mouse PD-1 Antibody (S-798-5)

Alexa Fluor® 647 Rat Anti-Mouse PD-1 Antibody (S-798-5)

Catalog Number: S0B80647 Application: FCM Reactivity: Ms Conjugation: Alexa Fluor® 647 Brand: Starter
Price:
Regular price $85 USD
Regular price Sale price $85 USD
Size:

For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Host Rat
Antigen PD-1
Synonyms Programmed cell death protein 1; Protein PD-1; mPD-1; CD279; Pd1; Pdcd1
Immunogen Recombinant Protein
Location Cell membrane
Accession Q02242
Clone Number S-798-5
Antibody Type Rat mAb
Isotype IgG1,k
Application FCM
Reactivity Ms
Positive Sample Concanavalin A treated C57BL/6 mouse splenocytes
Purification Protein G
Concentration 0.5 mg/ml
Conjugation Alexa Fluor® 647
Physical Appearance Liquid
Storage Buffer

PBS, 1% BSA, 0.09% sodium azide

Stability & Storage

12 months from date of receipt / reconstitution, 2 to 8 °C as supplied

Dilution


application dilution species
FCM 0.25μg per million cells in 100μl volume Ms

Background

Programmed cell death protein 1 (PD-1), also known as CD279, is a type I transmembrane protein and a member of the CD28 immunoglobulin superfamily, encoded by the _PDCD1_ gene. It is primarily expressed on the surface of various immune cells, including T cells, B cells, macrophages, dendritic cells, and natural killer cells. PD-1 plays a crucial role in regulating immune responses by binding to its ligands, PD-L1 (B7-H1) and PD-L2 (B7-DC), which are expressed on antigen-presenting cells and tumor cells. When PD-1 interacts with its ligands, it triggers inhibitory signals that downregulate T cell activity, preventing excessive immune responses and promoting self-tolerance. However, this pathway can also be exploited by cancer cells to evade immune surveillance, leading to tumor progression. As a result, PD-1 has become a key target in cancer immunotherapy, with several anti-PD-1 antibodies approved for treating various cancers, achieving significant and durable efficacy in some patients.

Picture

FC

C57BL/6 mouse splenocytes treated overnight with 3 μg/ml Concanavalin A (right panel) or untreated (left panel) were stained with Brilliant Violet 421™ Rat Anti-Mouse CD3 and SDT Alexa Fluor® 647 Rat Anti-Mouse PD-1 Antibody at 0.5 μl/test. Flow cytometry and data analysis were performed using Agilent NovoCyte Quanteon and FlowJo™ software.